![]() |
||
| home/products/Your Health/Vision | ||
| Vision | ||||||||
| blood sugar cardiovascular childrens digestion emotional immune system joints mens/prostate energy smoking sports nutrition vision weight management womens For orders & info: |
In the last decade or so, there is increasing research that oxidative factors and free radical damage may play an important role in the development of AMD. It has been postulated that treatment with high levels of antioxidants and other nutrients may slow down and possibly reverse some of the effects of macular degeneration. In a study published in the Archives of Ophthalmology from 1988, zinc was found to have some beneficial effect in the treatment of macular degeneration. In a subsequent study published in Archives of Ophthalmology from 1994, the data suggested a protective effect for AMD with high levels of vitamin E along with an antioxidant index composed of ascorbic acid, vitamin E and beta carotene. Another study published by Seddon in JAMA (1994) indicated that certain carotenoids lowered the risk of AMD by 43%, those specific carotenoids being lutein and zeaxanthin. The most dramatic effect was noted with lutein. Those people taking approximately 6 mg of lutein per day had an amazing 57% lower risk for AMD when compared to those whose consumption was lower (approximately 0.5 mg per day). Oxidation seems to play a significant role in the development of cataracts. Several epidemiologic studies indicated that patients with the lowest levels of vitamins C, E and carotenoids in their blood were more likely to suffer cataract formation. In one study published in 1997, in a large group of nurses ages 56 to 71, those nurses with the highest intake of vitamin C had a 77% lower prevalence of early lens opacities and an 83% lower prevalence of moderate cataracts compared to women who did not use vitamin C supplementation. Several nutrients have been shown to be of value in glaucoma, including magnesium, alpha lipoic acid, vitamins C and B12.
Ocupower®
Multi-Vitamin,
a propietary product from NSI, is currently in a clinical trial
for patients with macular degeneration. Without question it
is the best ocular nutraceutical product on the market. |
|||||||
Privacy Policy Site Terms of Use Terms and Conditions of Sale Copyright ©1999-2000 vitacost.com
Designated trademarks and brands are the property of their respective owners.